Luxembourg · Seed–Late Stage · 42 people tracked
Also known as EQT PARTNERS ASIA LIMITED · EQT Partners Japan K.K. · EQT REAL ESTATE, LLC
Investment thesis
EQT Life Sciences targets innovative life sciences companies focused on therapeutics, medical devices, diagnostics and healthtech worldwide. It seeks the most innovative solutions to the greatest unmet clinical needs, backing scientists, clinicians and entrepreneurs with capital plus strategic, clinical, operational, financial and commercial support. The firm aims to transform cutting-edge scientific innovation into impactful healthcare solutions while striving for superior investor returns. With a 30-year track record, it has raised around 3.5 billion euros across 12 private funds and three investment strategies (Life Sciences Funds, Health Economic Funds, and a Dementia Fund).
Source: firm website, verified Aug 3, 2026.
Team · 42 people
from the firm's website & curated & public directories
What they invest in
from 28 of 31 portfolio companiesBiotech ×20Healthtech ×19Medical Devices ×15AI & Machine Learning ×8Deep Tech ×7Digital Health ×4Enterprise Software ×3Consumer ×1
HQs:United States×8Belgium×4Netherlands×3Germany×1Denmark×1Spain×1
Investments · 31 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 42024 · 22023 · 52020 · 12019 · 114 dated
Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.
BiotechHealthtechMedical DevicesAntwerp, BE
Tim Knotnerus(Chief Executive Officer)
Co-investorsAdBio partnersAndera PartnersAsabys PartnersCanaan PartnersPontifax Venture CapitalV-Bio Ventures+1 more
ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.
BiotechHealthtechMedical Devices
Dr. Mark Throsby(Chief Executive Officer)
Co-investorsMRL Ventures FundV-Bio VenturesVIVES PartnersSambrinvestWallonie Entreprendre
Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.
AI & Machine LearningBiotech
Co-investorsBioGeneration VenturesBOMCurie CapitalKurma PartnersV-Bio Ventures
Egle Therapeutics develops targeted immunotherapy drugs by leveraging regulatory T cell (Treg) biology to treat autoimmune diseases and cancer.
Biotech
Fiorella Kotsias(Chief Scientific Officer)inBernard Vanhove(Chief Development Officer)in
BoardMichel Detheux(Chairman)in
Co-investorsFund+JDRF T1D Fund
Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.
BiotechHealthtechMedfield, US
Roger Heerman(Chief Business/Operating Officer / Co-Founder)inFrazer Morgan(Chief Development Officer / Co-Founder)Robert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)
BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)
Co-investors5AM VenturesAtlas VentureRA CapitalSixty Degree CapitalVivo CapitalGimv+1 more
MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.
BiotechHealthtech
PerBengt(CSO)
Co-investorsAdjuvant CapitalIndustrifondenOrbiMedPureos BioventuresSanofi VenturesSunstone Capital+2 more
Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.
BiotechHealthtechMedical DevicesGhent, BE
Co-investorsNewton BiocapitalBlackRockKreos CapitalRosetta Capital Ltd.VI PartnersBootstrap Europe+2 more
VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings.
BiotechHealthtechMedical Devices
Pieter ReitsmaJohn Glasspool(Chief Executive Officer)
Co-investorsSound BioventuresYsios CapitalBioGeneration VenturesEICInkefUNIIQ+2 more
Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Luc Dochez(Chair and Founder)Josh Mandel-Brehm(Co-Founder)
Co-investorsDroia VenturesKurma PartnersPureos BioventuresSeroba Life SciencesEurazeoIdinvest Partners
Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.
BiotechHealthtechPalo Alto, US
Luis Pena(Executive Officer, Director)inJanice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)
Board seatFelice Verduyn - Van Weegen· per SEC Form D · $115.5M raise · filed Jan 2025
Co-investorsAndera PartnersAvego BioScience CapitalB Capital GroupB4 CapitalBeiersdorf Innovation FundFemHealth Ventures+2 more
BiotechAmsterdam
Berndt Modig(Director)Dr. Robert Soiffer(Director)Otto Schwarz(Director)Subhanu Saxena(Director)Scott A. Holmes(Chief Financial Officer)James Joy(Executive Officer)
Board seatMartijn KleijwegtMark Wegter· per SEC Form D · $18.4M raise · filed Jun 2019
Lumeon provides an automated care orchestration platform that pulls data from health systems' care processes and existing systems and applies clinical intelligence to coordinate individualized patient care.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechBoston, US
Robbie Hughes(CEO and Founder)
Board seatRudy Dekeyser· per SEC Form D · $12M raise · filed Aug 2023
Co-investorsEndeavour VisionFraserOptum VenturesTechstarsAmadeus Capital Partners
1X is an AI and robotics company developing general-purpose humanoid robots for home and industrial use.
AI & Machine LearningConsumerHardwareRoboticsPalo Alto, US
Bernt Øyvind Børnich(CEO)Bernt Børnich(Founder)in
Co-investorsAlliance VCAlliance VentureEQT VenturesSamsung NextSandwaterSkagerak Capital+8 more
Co-investorsAndera PartnersCTI Life Sciences Fund L.P.Kurma PartnersLSP (Life Sciences Partners)Sofinnova Partners
Atalanta is a mathematical AI company that provides software verification and formal methods capabilities to ensure provably correct decision-making in complex systems for high-stakes missions in energy, space, and defense sectors.
AI & Machine LearningDeep TechDefense Tech
Jonathan Ring(Founder)in
Co-investorsFelicis Venturesabrdn plcF-Prime Capital
Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.
BiotechDeep TechHealthtechMedical Devices
Co-investorsF-Prime CapitalNovartis Venture FundRiverVest Venture PartnersSanofi Venturesabrdn plc
Cambridge Vision Technology develops diagnostic hardware and software for detecting Alzheimer's disease and other neurodegenerative conditions through retinal imaging and biomarker analysis.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, US
Developer of the EmboTrap stroke treatment device for removing clots from the brain; acquired by Johnson & Johnson.
Co-investorsLSP (Life Sciences Partners)Western Development Commission
Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.
HealthtechMedical Devices
Co-investorsAtlantic Bridge VenturesEnterprise IrelandFountain Healthcare PartnersWestern Development Commission
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)
BoardJoyce Erony(Director)inWilliam Harrington(Director)
Co-investorsAmzak HealthAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart Ventures+5 more
NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions.
BiotechHealthtechMedical Devices
Co-investorsBain Capital Life SciencesFrazier Life SciencesLSP (Life Sciences Partners)
Nobi manufactures intelligent lamps equipped with optical sensors and artificial intelligence to detect falls and monitor health for elderly care in residential facilities and home settings.
AI & Machine LearningHealthtechIoT
Co-investors15th RockAngelini VenturesPMV
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.
BiotechHealthtechMedical Devices
Ilise Lombardo(Chief Executive Officer)Volker Knappertz(Executive Vice President of Research & Development)Michael Samar(Chief Financial Officer)Rob Lasser(Chief Medical Officer)
Co-investorsBioMedPartnersJeito CapitalRoche Venture FundSofinnova PartnersEQTForbion+2 more
Onera Health provides clinical-grade remote diagnostics and monitoring solutions for healthcare professionals, with an initial focus on sleep health.
Digital HealthHealthtechMedical DevicesEindhoven, NL
Co-investors15th RockLSP (Life Sciences Partners)imec.xpandInnovation Industries
PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally.
BiotechDeep TechHealthtechMedical DevicesMol, BE
Sven van den berghe(CEO)Christophe Malice(CBO)Samy Bertrand(CTO)Yves Sterckx(Director of Finance & Administration)Philippe Vanwolleghem(Director Quality, Regulatory Affairs & HSE)
Co-investorsKorysKurma PartnersLSP (Life Sciences Partners)PMV
Payrails provides a modular financial operating system for enterprises that manages payment and financial workflows.
Enterprise SoftwareFintechSaaSBerlin, DE
Emre Talay(Founder)inNicolas Thouzeau(Founder)Orkhan Abdullayev(Founder)
Co-investorsAndreessen HorowitzDeBa VenturesEQT VenturesGeneral Catalyst
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)Roet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)Jason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)
Co-investorsDroia VenturesMC Healthcare VenturesMission BiocapitalMitsui Global InvestmentSanofi VenturesSV Health Investors+6 more
Sana is an AI lab that develops agentic AI systems to help teams access knowledge, automate repetitive work, and learn.
AI & Machine LearningEnterprise SoftwareFuture of WorkStockholm, SE
Co-investorsAcequia Capital (AceCap)EQT VenturesLeksell Social VenturesMenlo VenturesNew Enterprise Associates (NEA)Workday Ventures
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)
Co-investorsNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalAsabys PartnersCriteria Bio Ventures+2 more
Co-investorsatai Life SciencesAtaiBeckleyICONIQMaRS
Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology.
BiotechDeep TechHealthtechMedical Devices
Eliane Schutte(Chief Executive Officer)
Co-investorsKurma PartnersVI PartnersYsios CapitalInvest-NL
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioNeuraviacq. by Johnson & Johnson
Portfolio news
latest coverage across their companies
Agomab Therapeutics · investing.com · Aug 10, 2026
Xeltis · med-techinsights.com · Aug 6, 2026
Evommune · stocktitan.net · Aug 6, 2026
Atalanta · castleplacement.com · Jul 9, 2026
Quralis · nasdaqprivatemarket.com · Apr 3, 2026
Neurent Medical · mondaq.com · Feb 26, 2026
Payrails · trysignalbase.com · Feb 9, 2026
Frequently asked questions
- How many investments has EQT Life Sciences made?
- EQT Life Sciences has 8 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does EQT Life Sciences invest at?
- EQT Life Sciences invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is EQT Life Sciences's typical check size?
- EQT Life Sciences typically writes checks of $11M – $66M.
- What sectors does EQT Life Sciences focus on?
- EQT Life Sciences focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Sector Agnostic.
- Where is EQT Life Sciences located?
- EQT Life Sciences is headquartered in Luxembourg, LU.
- Does EQT Life Sciences lead rounds?
- Yes, EQT Life Sciences leads investment rounds.
- Who does EQT Life Sciences co-invest with?
- EQT Life Sciences most often shares deals with LSP (Life Sciences Partners), 15th Rock, Kurma Partners, among 15 tracked co-investors.
Media · Podcasts & interviews
from their channelEQT Value Creation Day in London 2026
EQT
EQT AB Annual Shareholders' Meeting 2026
EQT
Per Franzen and Jean Eric Salata on CNBC's Squawk Box Asia
EQT
India's Investment Journey with Hari Gopalakrishnan
EQT
How Being an “Outsider” Could Give You an Inside Advantage
EQT
Stop Trying to Be Like Everyone Else, Says Our Founder
EQT
Co-investors · 49
Kurma Partners is a European healthcare-focused investment firm that co-founds and finances biotech and healthcare companies, working closely with research centers to translate scientific discoveries into high-tech companies.
Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in early-stage biotech and digital health companies focused on improving human health. It serves as Sanofi's entry point into the innovation ecosystem.
Andera Partners is an asset management firm specializing in private equity that partners with companies and their management to support sustainable growth. It has backed 377 companies over more than 20 years.
Ysios Capital is a life sciences investor that finances innovative biotech companies worldwide, providing resources to develop novel therapies for indications with high unmet medical needs.
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
▶37 more co-investors
US Venture PartnersOrbiMedForbion5AM VenturesAtlantic Bridge VenturesPontifax Venture CapitalSeroba Life SciencesMC Healthcare VenturesMission BiocapitalAPERTURE Venture PartnersSignet Healthcare PartnersFounder CollectivePlug and Play VenturesBalderton CapitalCreandumAntlerARCH Venture PartnersEarlybird Venture CapitalXtripe AngelsOUP (Osage University Partners)Versant VenturesSR One Capital ManagementAbingworthIterative Instinct CapitalPfizer Venture InvestmentsPivotal Life SciencesBusiness Growth FundAdvent Life SciencesVantagePoint Capital PartnersSamsara BioCapitalIllumina VenturesCatalio Capital ManagementCasdin CapitalTheVentureCityBioqube VenturesPappas CapitalStanley Ventures
Firms observed investing alongside EQT Life Sciences, from public investor directories. Shared companies are the overlap with EQT Life Sciences's recorded portfolio.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Blackstone Life Sciences (BXLS) is Blackstone's life sciences investment arm that designs, funds and executes clinical trials to advance late-stage pharmaceutical, biotech and medical technology products to market.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.